{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:18Z","timestamp":1793289558844,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1053\/j.gastro.2013.04.055","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T19:44:59Z","timestamp":1367955899000},"page":"357-365.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Young Women With Polycystic Liver Disease Respond Best to Somatostatin Analogues: A Pooled Analysis of Individual Patient Data"],"prefix":"10.1053","volume":"145","author":[{"given":"Tom J.G.","family":"Gevers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Inthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruggenenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2013.04.055_bib1","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hep.24036","article-title":"Medical and surgical treatment options for polycystic liver disease","volume":"52","author":"Drenth","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.04.055_bib2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2011.04.030","article-title":"Polycystic liver diseases: congenital disorders\u00a0of cholangiocyte signaling","volume":"140","author":"Strazzabosco","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.04.055_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2013.04.055_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2013.04.055_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2013.04.055_bib6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1053\/j.gastro.2004.02.023","article-title":"Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease","volume":"126","author":"Drenth","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.04.055_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/ans.12049","article-title":"Surgical management of cystic lesions in the liver","author":"Garcea","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1053\/j.gastro.2013.04.055_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrgastro.2012.254","article-title":"Diagnosis and management of polycystic liver disease","volume":"10","author":"Gevers","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2013.04.055_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0016-5085(95)90078-0","article-title":"Liver resection and cyst fenestration in the treatment of severe polycystic liver disease","volume":"108","author":"Que","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.04.055_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.04.055_bib11","article-title":"Pasireotide is more effective than octreotide in reducing hepato-renal cystogenesis in rodents with polycystic kidney and liver diseases","author":"Masyuk","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.04.055_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2013.04.055_bib13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial\u00a0of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2013.04.055_bib14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.04.055_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2013.04.055_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MOG.0b013e328343433f","article-title":"Somatostatin analogues for treatment of\u00a0polycystic liver disease","volume":"27","author":"Gevers","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2013.04.055_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2013.04.055_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases","volume":"31","author":"van Keimpema","year":"2011","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2013.04.055_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2013.04.055_bib20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2215\/CJN.02251205","article-title":"Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report","volume":"1","author":"Antiga","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2013.04.055_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11605-007-0376-8","article-title":"Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%","volume":"12","author":"van Keimpema","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1053\/j.gastro.2013.04.055_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1478-3231.2007.01595.x","article-title":"Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease","volume":"28","author":"Hoevenaren","year":"2008","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2013.04.055_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/jarr.2003.50005","article-title":"Cystic disease in women: clinical characteristics and medical management","volume":"10","author":"Chapman","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"10.1053\/j.gastro.2013.04.055_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840110619","article-title":"Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease","volume":"11","author":"Gabow","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.04.055_bib25","first-page":"1282","article-title":"Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease","volume":"26","author":"Sherstha","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.04.055_bib26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1053\/gast.2000.20184","article-title":"Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats","volume":"119","author":"Alvaro","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.04.055_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2008.070293","article-title":"Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease","volume":"172","author":"Alvaro","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2013.04.055_bib28","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/endo.139.5.5990","article-title":"Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures","volume":"139","author":"Djordjijevic","year":"1998","journal-title":"Endocrinology"},{"key":"10.1053\/j.gastro.2013.04.055_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2036.2011.04923.x","article-title":"The long-term outcome of patients with polycystic liver disease treated with lanreotide","volume":"35","author":"Chrispijn","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2013.04.055_bib30","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/ndt\/gfs152","article-title":"Somatostatin analog therapy for severe polycystic liver disease: results after 2 years","volume":"27","author":"Hogan","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.gastro.2013.04.055_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2013.04.055_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1665-2681(19)31406-1","article-title":"Polycystic liver disease: a clinical review","volume":"11","author":"Chandok","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2013.04.055_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.2007.03067.x","article-title":"A\u00a012-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly","volume":"68","author":"Andries","year":"2008","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1053\/j.gastro.2013.04.055_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1500489","article-title":"Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients","volume":"150","author":"van Thiel","year":"2004","journal-title":"Eur J Endocrinol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508513007075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508513007075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:05:25Z","timestamp":1758035125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508513007075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0016508513007075"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2013.04.055","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Young Women With Polycystic Liver Disease Respond Best to Somatostatin Analogues: A Pooled Analysis of Individual Patient Data","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2013.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}